Chengzhi Cai Yaling Long Yanying Li Meijuan Huang
10.2147/OTT.S258067
Onco Targets Ther
2020 Aug 20;13:8313-8316.
nsclc intergenic alk intragenic alk non-eml4–alk target therapy
CC BY-NC
https://pubmed.ncbi.nlm.nih.gov/32903930/
Case Reports
PMC7445493
32903930
Coexisting of COX7A2L-ALK, LINC01210-ALK, ATP13A4-ALK and Acquired SLCO2A1-ALK in a Lung Adenocarcinoma with Rearrangements Loss During the Treatment of Crizotinib and Ceritinib: A Case Report
2020